Aging is the biggest challenge that mankind has to deal with in this century. The recent achievements of aging researches created new directions; (1) delaying aging; (2) realization of the healthy longevity; and (3) suppression of dysfunctions caused by aging. alpha-klotho was first identified as an aging gene and later shown to have several functions depending on its intracellular, membrane, and extra-cellular secreted forms. The intra-cellular form of alpha-Kl activates Ca2+ transport in the choroid plexus and kidney, and regulates PTH secretion in parathyroid glands by controlling the trafficking of Na+-K+-ATPase complex to plasma membrane. On the membrane, alphaKl forms a complex with FGF23 and FGFR1 and negatively regulates 1, 25(OH)2D synthesis and phosphate re-absorption in the kidney. The extracellular domains of alpha-Kl are homologous to family 1 beta-glycosidase. The analyses of sugar chains of alpha-Kl binding proteins and crystal structure of alpha-Kl revealed that alphaKl functions as a novel glucuronide-binding protein. A vicious cycle composed of abnormality of mineral homeostasis, calpain1 activation, and the increase in inflammatory cytokines and chemokines is involved in the onset and deterioration of aging related phenotypes of alpha-kl deficient mouse. Multiple agingrelated phenotypes were strikingly ameliorated by the functional suppressions of vicious cycle components. These findings allow us to propose that the modulation of vicious cycle components is a potential therapeutic option for delaying ageassociated organ pathology.
extracellular domains of alpha-Kl are homologous to family 1 beta-glycosidase. The analyses of sugar chains of alpha-Kl binding proteins and crystal structure of alpha-Kl revealed that alphaKl functions as a novel glucuronide-binding protein. A vicious cycle composed of abnormality of mineral homeostasis, calpain1 activation, and the increase in inflammatory cytokines and chemokines is involved in the onset and deterioration of aging related phenotypes of alpha-kl deficient mouse. Multiple agingrelated phenotypes were strikingly ameliorated by the functional suppressions of vicious cycle components. These findings allow us to propose that the modulation of vicious cycle components is a potential therapeutic option for delaying ageassociated organ pathology.
S4-2
Roles and mechanisms of cellular senescence in aging and cancer
○ Eiji Hara
Department of Molecular Microbiology, Research Institute for Microbial Diseases, Osaka University Cellular senescence is the state of essentially irreversible cell cycle arrest that can be induced by a variety of potentially oncogenic stimuli, such as telomere erosion, oxidative stress or activation of certain oncogenes and is therefore considered to act as an important tumor suppression mechanism. However, emerging evidence indicates that senescent cells may also promote deleterious side effects including chronic inflammation and cancer promotion.
It is therefore quite possible that accumulation of senescent cells in vivo may contribute to aging-associated intractable diseases. Here, I discuss the molecular events associated with these two faces of cellular senescence, focusing on the pro-inflammatory side effects. I believe that a better understanding of the molecular mechanisms involved will lead to new strategies for the prevention of aging and aging-associated diseases.
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S4-3 Epigenetic alterations in aged hematopoietic stem cells
○ Atsushi Iwama
Department of Cellular and Molecular Medicine, Graduate School of Medicine, Chiba University, Chiba, Japan
Hematopoietic stem cells (HSCs) show several characteristic phenotypes with aging, such as impaired repopulating capacity and a greater propensity for myeloid differentiation compared with young HSCs. Epigenetic alterations have been recognized as a hallmark of mammalian aging. This epigenetic drift is thought to be the result of the stochastic accumulation of epigenetic errors, but also induced by various aging stresses or acquired somatic mutations in epigenetic regulator genes. Although global H3K27me3 levels does not significantly change in mouse HSCs with aging, we found that Polycomb Repressive Complex (PRC) 2 target genes, which are marked with a repressive histone mark H3K27me3 in young HSCs, show a trend toward up-regulation in aged HSCs and mildly reduce H3K27me3 levels at their promoters. We confirmed some of the aging stresses induce decline in H3K27me3 levels in HSCs. These findings suggest that a decline in polycomb activity is associated with HSC aging. Of note, recurrent mutations in PRC2 genes have been identified in age-related myeloid malignancies; such as myelodysplastic syndrome (MDS) and myeloproliferative neoplasms (MPN), which are all clonal myeloid disorders originating from HSCs. We confirmed that the loss of Ezh2, an enzymatic component of PRC2, in mice markedly accelerates the development of agerelated myeloid malignancies. These findings suggest that aged-related decline in polycomb activity underlies the development of age-related HSC malignancies.
S4-4 Stem cells orchestrate hair follicle aging program
○ Emi Nishimura, Tomoki Kato, Hiroyuki Matsumura, Nan Liu
Medical Research Institute, Tokyo Medical and Dental University
Tissues and organs undergo structural and functional declines due to aging, yet the underlying mechanisms involved and whether the tissue aging is programed or not have been poorly understood. The hair follicle is a miniorgan of the skin that is specialized to grow hair. Hair follicle stem cells (HFSCs) and melanocyte stem cells (McSCs) reside in mammalian hair follicles to sustain the cyclic growth of pigmented hair during each hair cycle. To understand the mechanisms of tissue aging, we have studied the physiological aging-associated changes in murine and human hair follicles and their underlying mechanisms. In vivo fate analysis of stem cells in naturally aging hair follicles revealed that those stem cells undergo specific fate changes through the proteolysis of hemidesmosomal transmembrane collagen (COL17A1), thereby causing aberrant differentiation and depletion of those stem cells and the resultant typical hair aging phenotypes in a stepwise manner. Furthermore, we found that the expression of those aging phenotypes can be prevented by the forced expression of COL17A1 in HFSCs. These results demonstrate the existence of a stem cellcentric aging program as the core to orchestrate tissue aging. In this symposium, I will introduce the concept of stem cell division program for aging and will discuss the role in tissue/organ aging.
S4-5
Mouse Models for aging research -Senescence Accelerted Mouse (SAM) - The Senescence-Accelerated Mouse (SAM) strains provide a unique model system for the study of the aging process in higher organisms. The SAM strains were developed in 1981 and have been used in many studies of aging, age related diseases and anti-aging treatments. The SAM strains include the accelerated senescenceprone SAMP series (SAMP1, SAMP6, SAMP8 and SAMP10) and the accelerated senescenceresistant SAMR1 which serve as a control for the SAMP strains. The SAMP strains grow normally, but they show early signs of aging and their life spans are shorter than SAMR1. Molecular genetic characterization of the SAM strains revealed that they might be a group of recombinant inbred strains involving the AKR/J strain and an unknown strain. SAMP strains spontaneously manifested various age-related patho-biological phenotypes that were often characteristic enough to differentiate the strains. The hyperoxidative status may incur accelerated senescence in SAMP strains. We have revealed delayed senescence in SAMP1 mice given supplementation with reduced form of coenzyme Q10. Activation of mitochondrial function by the reduction in cytosolic Ca 2+ , increased cAMP, induction of Sirtuin genes and PGC-1 α may protect against the progression of aging and the symptoms of age-related diseases in SAMP1 mice.
S4-6
Mouse phenotyping pipeline for late onset screen and Construction of aged mouse production system
